Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients? [Meeting Abstract]

Basit Öğe Kaydı
dc.authoridduran, Ayse Ocak/0000-0002-1703-726X
dc.authoridDuzkopru, Yakup/0000-0003-2314-5870
dc.authoridHacıbekiroğlu, İlhan/0000-0002-0333-7405
dc.authoridUysal, Mukremin/0000-0002-8524-0665
dc.authorwosidduran, Ayse Ocak/ABA-7090-2021
dc.authorwosidDuzkopru, Yakup/GLT-1944-2022
dc.authorwosidHacıbekiroğlu, İlhan/JCN-7264-2023
dc.authorwosidBerk, Veli/IXE-0017-2023
dc.authorwosidÖZASLAN, ERSİN/V-3556-2017
dc.authorwosidUysal, Mukremin/B-8956-2014
dc.contributor.authorOzkan, Metin
dc.contributor.authorBozkurt, Oktay
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorDuzkopru, Yakup
dc.contributor.authorUysal, Mukremin
dc.contributor.authorKaraca, Halit
dc.date.accessioned2024-06-12T11:22:26Z
dc.date.available2024-06-12T11:22:26Z
dc.date.issued2015
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25929
dc.identifier.volume33en_US
dc.identifier.wosWOS:000358036903163en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleIs sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients? [Meeting Abstract]en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu